Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

71.98 -11.57 (-13.85%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Think It's Too Late to Buy Tempus AI? Here's the Biggest Reason Why There's Still Time. ↗

May 02, 2025

Via The Motley Fool

Topics Artificial Intelligence

Jim Cramer: Sunrun Had 'Bad Couple Of Quarters,' ExlService Holdings Is 'Solid' ↗

May 02, 2025

On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying BlackRock, Inc. because "it's going to be a great position."

Via Benzinga

Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment

May 01, 2025

From Tempus AI, Inc.

Via Business Wire

Is This the Best Nancy Pelosi Stock to Buy After a 40% Pullback? ↗

April 30, 2025

Via The Motley Fool

Topics Artificial Intelligence

Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

April 29, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:POAI),(NASDAQ:ADMA) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection

April 29, 2025

From Tempus AI, Inc.

Via Business Wire

Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

April 29, 2025

From FN Media Group LLC

Via GlobeNewswire

Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform

April 28, 2025

From Tempus AI, Inc.

Via Business Wire

Bitdeer Tech And Tempus AI Are Among Top 18 Mid-Cap Gainers Last Week (Apr 21-Apr 25): Are The Others In Your Portfolio? ↗

April 27, 2025

Top mid-cap stock performers last week: Ascentage Pharma, Ardagh Metal, Bitdeer Tech, Pegasystems, Impinj, Lufax, Tempus AI, Kymera Therapeutics.

Via Benzinga

Topics Artificial Intelligence

Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025

April 25, 2025

From Tempus AI, Inc.

Via Business Wire

Tempus to Report First Quarter 2025 Financial Results on May 6

April 24, 2025

From Tempus AI, Inc.

Via Business Wire

Beyond The Numbers: 9 Analysts Discuss Tempus AI Stock ↗

April 24, 2025

Via Benzinga

Topics Artificial Intelligence

Tempus AI Is Skyrocketing Today -- Is the Stock a Buy Right Now? ↗

April 23, 2025

Via The Motley Fool

Topics Artificial Intelligence Government Stocks

Tempus AI Stock Is Ripping Higher Wednesday: What's Fueling The Move? ↗

April 23, 2025

Tempus AI Inc (NASDAQ:TEM) shares are surging Wednesday after the company announced a multi-year collaboration with AstraZeneca PLC (NASDAQ:AZN) and Pathos AI.

Via Benzinga

Topics Artificial Intelligence

Tempus AI Stock Surges Nearly 16% on Strategic Partnerships and AI-Driven Oncology Breakthroughs

April 23, 2025

April 23, 2025 – Tempus AI, Inc. (NASDAQ: TEM), a leading precision medicine company leveraging artificial intelligence (AI) for diagnostic and therapeutic advancements, saw its Class A Common Stock...

Via MarketMinute

Topics Artificial Intelligence Stocks World Trade

Why Tempus AI Stock Is Skyrocketing Today ↗

April 23, 2025

Via The Motley Fool

Topics Artificial Intelligence

Amphenol Posts Better-Than-Expected Results, Joins SAP, Tesla, Pegasystems And Other Big Stocks Moving Higher On Wednesday ↗

April 23, 2025

Via Benzinga

Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology

April 23, 2025

From Tempus AI, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

April 18, 2025

Via Benzinga

Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S.

April 18, 2025

From Tempus AI, Inc.

Via Business Wire

Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations

April 16, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:ILMN),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:MDAI) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

3 Hot New IPOs Defying the 2025 Market Slump

April 14, 2025

Tempus AI, ServiceTitan, and CoreWeave are 2025 IPO standouts, defying a down market. Here’s how they’re beating the S&P 500 so far this year.

Via MarketBeat

Topics Artificial Intelligence Initial Public Offering Stocks

Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing ↗

April 14, 2025

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

Via Benzinga

Topics Animal Testing

Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations

April 16, 2025

From FN Media Group LLC

Via GlobeNewswire

Cathie Wood's Thursday Plays: Healthcare AI And Crypto — Ark Scoops Up Tempus AI and Coinbase Stock Amid Trump Tariff Crash ↗

April 10, 2025

Ark Invest made major buys in Tempus AI and Coinbase on Thursday, as markets slid amid economic uncertainty and Trump's new 145% China tariffs.

Via Benzinga

Topics Artificial Intelligence Government

Cathie Wood Loads Up On $18.2 Million Worth Of Nvidia Stock, Adds $5.8 Million Worth Of Amazon Shares To Her Shopping Cart Amid Trump Tariff Upheaval ↗

April 08, 2025

Cathie Wood's Ark Invest made bold moves Tuesday, buying millions worth of Amazon, NVIDIA, Tempus AI, and Coinbase shares across its ETFs.

Via Benzinga

Topics Artificial Intelligence Government

Does Nvidia-Backed CoreWeave's Lackluster IPO Signal the AI Stock Boom Is Officially Over? ↗

April 02, 2025

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering

Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting

March 29, 2025

From Tempus AI, Inc.

Via Business Wire

4 Healthcare Stocks With Massive Gains—and More to Come

March 29, 2025

Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.

Via MarketBeat

Topics Artificial Intelligence Economy World Trade

Tempus to Present at the 24th Annual Needham Virtual Healthcare Conference

March 26, 2025

From Tempus AI, Inc.

Via Business Wire

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.